AI Driven Precision Oncology

Advance discovery, innovation, and increase the likelihood of trial success with real-world clinical and molecular data, including DNA, RNA , Protein and pathology images.

Arrant leverages best-in-class laboratories to provide a variety of next-generation sequencing (NGS) tests and targeted arrays to support testing needs from discovery through to commercializatio

Arrant expedites CDx development by leveraging a large in-house Bio Repository, a comprehensive Onco-Genomics Lab

Our vast tumor organoid repository enables new possibilities for therapy selection and drug discovery

We offer a broad range of technologies to support your R&D, from genotyping to methylation to NGS to Proteomics.

Accelerate your clinical trials with unparalleled access to world largest pool of treatment naive patients, 31 cancer center sites and and a 90 day Regulatory approval and site initiation

Every patient is unique. Your treatment should be, too.